ALNACEF S INJECTION 1VIAL

Product Introduction:

Alnacef S Injection is a combination medication containing two active ingredients: Ceftriaxone (1000mg) and Sulbactam (500mg). Ceftriaxone belongs to the class of cephalosporin antibiotics, while Sulbactam is a beta-lactamase inhibitor. This combination is used to treat various bacterial infections by enhancing the effectiveness of Ceftriaxone against bacteria that produce beta-lactamase enzymes.

Alnacef S Injection should only be administered under the supervision of a healthcare professional. Do not miss any scheduled appointments for taking this medicine. The course of the treatment must be completed even if you feel better. Sudden discontinuation of the treatment may affect the potency of the medicine.

Some common side effects of this medicine are nausea, vomiting, diarrhea, indigestion, etc. If any of the side effects get aggravated, you must consult your doctor immediately. If you experience any allergic reaction (rashes, itching, swelling, shortness of breath, etc.), you must seek immediate medical help.

Before taking this medicine, you should tell your doctor if you are taking any medicines for any health condition. Pregnant or breastfeeding women should also consult with their doctor before taking it. Avoid drinking alcohol as it can cause excessive drowsiness with this medicine. It usually does not impair your ability to drive, but you should not drive if it makes you feel sleepy or dizzy. You must take adequate rest for a faster recovery, also take a healthy diet and drink plenty of water. Your doctor may ask for a few laboratory and diagnostic tests to know the effects of the medicine on your body.

Benefits:

1. Broad-Spectrum Antibiotic: Ceftriaxone is effective against a wide range of bacterial infections, including respiratory tract infections, urinary tract infections, skin and soft tissue infections, septicemia, and intra-abdominal infections.
2. Beta-Lactamase Inhibition: Sulbactam inhibits beta-lactamase enzymes produced by certain bacteria, thereby preventing the breakdown of Ceftriaxone and extending its spectrum of activity.
3. Synergistic Action: The combination of Ceftriaxone and Sulbactam provides synergistic antibacterial activity, enhancing the overall efficacy of the treatment.
4. Parenteral Administration: Alnacef S Injection offers a convenient parenteral formulation, allowing for rapid administration and onset of action in critically ill patients or those unable to take oral medications.

Side Effects:

Common side effects of Alnacef S Injection may include:

• Injection site reactions (pain, redness, swelling)
• Diarrhea
• Nausea
• Vomiting
• Headache
• Allergic reactions (rare but may be severe)

Serious side effects are uncommon but may include:

• Clostridium difficile-associated diarrhea (CDAD)
• Liver dysfunction (hepatotoxicity)
• Hypersensitivity reactions, including anaphylaxis

Usage Guidelines:

• Dosage: The dosage of Alnacef S Injection should be determined by a healthcare professional based on the severity of the infection, the patient’s age, weight, and renal function.
• Route of Administration: Alnacef S Injection is administered intravenously (IV) or intramuscularly (IM) by a qualified healthcare provider.
• Reconstitution: Follow the manufacturer’s instructions for reconstitution and dilution of the injection before administration.
• Frequency: The injection is typically administered once or twice daily, depending on the indication and severity of the infection.
• Duration: Complete the full course of treatment as prescribed by the healthcare provider, even if symptoms improve before the medication is finished.

Drug Interactions:

• Inform your healthcare provider about all medications, including prescription, over-the-counter, and herbal products, that you are taking, as they may interact with Alnacef S Injection.
• Concomitant use of other antibiotics, particularly those with similar mechanisms of action, may increase the risk of adverse effects or decrease the effectiveness of treatment.
• Consult a healthcare professional for specific guidance on potential drug interactions based on individual medical history and current medications.

Always use Alnacef S Injection under the supervision of a healthcare professional, and promptly report any adverse reactions or concerns during treatment.

SAFETY ADVICE

Alcohol

SAFE

Consuming alcohol with Alnacef S Injection does not cause any harmful side effects.

Pregnancy

SAFE IF PRESCRIBED

Alnacef S Injection is generally considered safe to use during pregnancy. Animal studies have shown low or no adverse effects to the developing baby; however, there are limited human studies.

Breast feeding

CAUTION

Alnacef S Injection should be used with caution during breastfeeding. Breastfeeding should be held until the treatment of the mother is completed and the drug is eliminated from her body.

Driving

UNSAFE

Alnacef S Injection may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.

Kidney

CONSULT YOUR DOCTOR

There is limited information available on the use of Alnacef S Injection in patients with kidney disease. Please consult your doctor.

Liver

CAUTION

Alnacef S Injection should be used with caution in patients with severe liver disease. Dose adjustment of Alnacef S Injection may be needed. Please consult your doctor.
Dose adjustment of Alnacef S Injection is not recommended in patients with mild to moderate liver disease.